Yang R Z, Lee M J, Hu H. Identification of omentin as a novel depot-specific adipokine in human adipose tissue:possible role in rnadulating insulin action [J]. American Journal of Physiology Endocrinology and Metabolism, 2006.E1253.
|
Fukuhara A, Matsuda M, Nishizawa M. Visfatin:a protein secreted by visceral fat that mimics the effects of insulin [J]. Science, 2005, (5708):426.
|
Winkler G, Cseh K. Molecular mechanisms of insulin resistance in obesity and type 2 diabetes mellitus [J]. Orvosi Hetilap, 2009, (17):771.
|
Kraliseh S, Klein J, Bluher M, el al. Therapeutic perspectives of adipocytokines [J]. Expert Opin Phammeother, 2005.863.
|
Rajala MW, Obiei s, Scherer PE. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production [J]. Journal of Clinical Investigation, 2003.225.
|
Okamoto Y, Kihara S, Funahashi T. BAdiponectin:A key adipocytokine in metabolic syndrome [J]. Clinical Science(London), 2006.267.
|
Liu R, Wang X, Bu P. Omentin-1 is associated with carotid atheroselerosis in patients with metabolic syndrome [J]. Diabetes Research and Clinical Practice, 2011.21.
|
Shibata R, Takahashi R, Kataoka Y. Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men [J]. Hypertension Research, 2011, (12):1309.
|
蔡润策, 魏丽, 吴海娅. 肥胖及2型糖尿病患者血清网膜素水平及其相关因素分析 [J]. 中华医学杂志, 2008, (16):1096.doi: 10.3321/j.issn:0376-2491.2008.16.005.
|
Pan H Y, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes [J]. Diabetes Research and Clinical Practice, 2010(1):29.
|